By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Advaxis, Inc. 

The Technology Centre of New Jersey
675 U.S. Route One, South
North Brunswick  New Jersey  08902   U.S.A.
Phone: 732-545-1590 Fax: 732-545-1084


SEARCH JOBS

Advaxis is a clinical-stage biotechnology company developing cancer immunotherapies that enlist the body’s own immune system to fight cancer.

YEAR FOUNDED:

2002

LEADERSHIP:

CEO: Daniel O’Connor

CFO: Sara Bonstein

CSO (Scientific): Robert Petit

JOBS:

Please click here for Advaxis job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.

FOLLOW ADVAXIS:



Key Statistics


Email:
Ownership: Public

Web Site: Advaxis
Employees:
Symbol: ADXS
 



Industry
Biotechnology






Company News
Advaxis (ADXS) Lead Immunotherapy Candidate Continues To Build Recognition Among Industry Leaders 7/13/2017 7:18:42 AM
Effective Immediately: Advaxis (ADXS) CEO Resigns, Interim Leader Named 7/7/2017 6:01:36 AM
Advaxis (ADXS)’ Axalimogene Filolisbac Data Selected For Poster Presentation At ESGO 2017 6/26/2017 8:26:41 AM
Advaxis (ADXS) To Present At 2017 BIO International Convention 6/16/2017 7:25:58 AM
Advaxis (ADXS) To Be Featured On Worldwide Business With Kathy Ireland 6/14/2017 8:12:25 AM
Advaxis (ADXS) Details Registrational Trials, EU Regulatory And Commercial Plans At Annual Investor & Analyst Day 6/13/2017 10:51:33 AM
Advaxis (ADXS) To Webcast Investor & Analyst Day 2017 6/9/2017 7:16:12 AM
Synthetic Genomics, Inc. Launches cGMP Suite For Pharmaceutical Quality Manufacturing Of Synthetic DNA For Advaxis (ADXS)' Clinical Trials 6/1/2017 8:41:57 AM
Advaxis (ADXS) And Bristol-Myers Squibb (BMY) Announce Clinical Collaboration To Evaluate ADXS-DUAL And Opdivo (Nivolumab) In Metastatic Cervical Cancer 5/30/2017 6:40:29 AM
Advaxis (ADXS) To Host Investor & Analyst Day On June 12 5/18/2017 9:48:19 AM
12345678910...
//-->